Acasă › Carcinom cu celule scuamoase de cap și gât › Ohio › Columbus
Studii clinice pentru Carcinom cu celule scuamoase de cap și gât în Columbus, OH
20 studii pentru Carcinom cu celule scuamoase de cap și gât caută participanți în și în jurul orașului Columbus (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
În curs de recrutareFaza 3
- Ohio State University Comprehensive Cancer Center, Columbus
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
În curs de recrutareFaza 1
- ALX Center 10, Columbus
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
În curs de recrutareFaza 3
- Ohio State University, Columbus
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
În curs de recrutareFaza 2
- Ohio State University Comprehensive Cancer Center, Columbus
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
În curs de recrutareFaza 2
- Research Site, Columbus
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
În curs de recrutareFaza 1/2
- Ohio State University, Columbus
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
În curs de recrutareStudiu observațional
- Ohio State University, Columbus
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
În curs de recrutareFaza 2
- Ohio State University, Columbus
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
În curs de recrutareFaza 2/3
- Ohio State University Comprehensive Cancer Center, Columbus
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
În curs de recrutareFaza 2
- Ohio State University Comprehensive Cancer Center, Columbus
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
În curs de recrutareFaza 1/2
- The Ohio State University, Columbus
SMP-3124LP in Adults With Advanced Solid Tumors
În curs de recrutareFaza 1/2
- Ohio State University, Columbus
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
În curs de recrutareFaza 1/2
- Ohio State University, Columbus
Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer
În curs de recrutareFaza 1
- Ohio State University Comprehensive Cancer Center, Columbus
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
În curs de recrutareFaza 1/2
- Stefanie Spielman Comprehensive Breast Center, Columbus
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
În curs de recrutareFaza 3
- Ohio State University, James Cancer Hospital and Solove Research Institute, Columbus
Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal Cancer
În curs de recrutareFaza 2
- Ohio State University Comprehensive Cancer Center, Columbus
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
În curs de recrutare
- Ohio State University Medical Center, Columbus
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
În curs de recrutareFaza 1/2
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
În curs de recrutareFaza 1/2
- The Ohio State University, Columbus
Studii pentru Carcinom cu celule scuamoase de cap și gât în alte orașe
- Houston, TX47 studii
- Los Angeles, CA42 studii
- Boston, MA40 studii
- New York City, NY39 studii
- Nashville, TN39 studii
- St. Louis, MO28 studii
- Arlington, VA26 studii
- Philadelphia, PA26 studii
- Chicago, IL26 studii
- Atlanta, GA24 studii
- San Antonio, TX22 studii
- New Haven, CT22 studii
Alte studii în Columbus
- Cancer pulmonar cu celule non-pătrate57 studii
- Cancer de sân40 studii
- Cancer ovarian39 studii
- Cancer (toate tipurile)38 studii
- Cancer pulmonar37 studii
- Leucemie mieloasă acută35 studii
- Leucemie limfatică cronică28 studii
- Cancer metastatic27 studii
- Cancer endometrial25 studii
- Cancer de prostată24 studii
- Mielom multiplu24 studii
- Cancer colorectal24 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.